Integra Lifesciences Holdings Corp (NASDAQ:IART)

41.27
Delayed Data
As of Dec 08
 -0.04 / -0.10%
Today’s Change
33.44
Today|||52-Week Range
60.69
-26.40%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2015

2016

2017

2018
Operating ActivitiesNet Income / Starting Line-3.5M74.6M64.7M60.8M
 
 
 
 
 
Depreciation58.9M72.7M88.9M110.7M
 
 
 
 
 
Total Other Cash Flow56.4M-13.1M29.5M29.6M
 
 
 
 
 
Funds From Operations111.4M127.6M115.9M192.9M
 
 
 
 
 
Funds From/For Other Operating Expenses16.9M11.2M1.3M-1.7M
 
 
 
 
 
Net Cash Flow - Operating Activities94.5M116.4M114.5M194.6M
 
 
 
 
 
 
InvestingDecrease In Investments0.000.0017.0M0.00
 
 
Capital Expenditures-33.4M-47.3M-43.5M-77.7M
 
 
 
 
 
Fixed Asset Disposal1.4M541.0K46.7M27.1M
 
 
 
 
 
Net Assets From Acquisitions -328.9M0.00-1.2B0.00
 
 
 
Other Investing - Uses-7.1M0.000.000.00
 
 
Other Investing - Sources0.004.2M483.0K910.0K
 
 
 
 
Net Cash Flow Investing-367.9M-42.6M-1.2B-49.7M
 
 
 
 
 
 
FinancingShort Term Borrowings0.000.000.000.00--
Long Term Borrowings543.6M675.5M1.3B171.2M
 
 
 
 
 
Long Term Debt Reduction-468.9M-696.2M-117.0M-660.0M
 
 
 
 
 
Net Proceeds Stock Sale227.0M10.5M9.8M359.0M
 
 
 
 
 
Common Preferred Redeemed0.000.000.000.00--
Common Dividends0.000.000.000.00--
Cash Dividends Paid - Total0.000.000.000.00--
Other Sources - Financing3.8M0.000.000.00
 
 
Other Uses - Financing47.0M4.9M11.8M46.0M
 
 
 
 
 
Net Cash Flow - Financing258.5M-15.1M1.2B-175.8M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash-4.8M-4.7M10.7M-5.2M
 
 
 
 
 
 
Net Change In Cash-14.9M58.7M62.2M-30.9M